SAHPRA-2022-0038-V338

Type IB variation for application SAHPRA-2022-0038. Type IB variation: New Dosage Strength for Alzabistat — routine update

Variation Number
SAHPRA-2022-0038-V338
Type
Type IB
Application
SAHPRA-2022-0038
Change
CHG-2023-0038
Status
Submitted
Fee
€4,341
Submitted
2023-12-29
Approved
—
Description

Type IB variation: New Dosage Strength for Alzabistat — routine update